Papillary serous carcinoma of ovarian type of the testis with borderline differentiation.
Guarch
R
R
Rivas
A
A
Puras
A
A
Pesce
C
C
D015415:Biomarkers; D018394:CA-125 Antigen / Q000032:analysis; D002272:Carcinoembryonic Antigen / Q000032:analysis; D002454:Cell Differentiation; D018283:Cystadenocarcinoma, Papillary / Q000378:metabolism / Q000473:pathology*; D018284:Cystadenocarcinoma, Serous / Q000378:metabolism / Q000473:pathology*; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D007633:Keratins / Q000032:analysis; D016256:Lewis X Antigen / Q000032:analysis; D008297:Male; D008875:Middle Aged; D018396:Mucin-1 / Q000032:analysis; D010053:Ovary / Q000473:pathology; D009418:S100 Proteins / Q000032:analysis; D013736:Testicular Neoplasms / Q000378:metabolism / Q000473:pathology*; D013737:Testis / Q000737:chemistry / Q000473:pathology
D015415:Biomarkers; D018394:CA-125 Antigen; C400901:CAM 5.2 antigen; D002272:Carcinoembryonic Antigen; D016256:Lewis X Antigen; D018396:Mucin-1; D009418:S100 Proteins; D007633:Keratins